Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments, such as TMS or esketamine?
How have you gone about implementing esketamine treatment in your practice or institution?
Is there a role for administering IV ketamine immediately after ECT treatments in patients with difficult-to-treat major depressive disorder?
What antidepressant medications do you usually use alongside ketamine or esketamine treatment in patients with difficult-to-treat depression?
How have you gone about implementing TMS in your practice or institution?
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
How do you counsel patients with mild to moderate depression interested in using St. John's Wort?
Given some of the theoretical relationship between glutamate and OCD, do you ever consider the use of NMDA (or AMPA) antagonists for the treatment of refractory OCD?
What pharmacologic treatments have you found helpful in treating comorbid schizophrenia and OCD?
What is your approach for managing persistent psychotic symptoms of a hallucinogen-induced persisting psychotic disorder?
